
Loading, please wait...

Loading, please wait...







A prospective study evaluates an MRI-first prostate cancer screening strategy to detect grade group ≥ 2 disease. By reserving biopsies for MRI-suspicious or high-risk PSA findings, clinicians safely reduce unnecessary procedures and overdiagnosis while preserving oncological safety.

A prospective study demonstrates that transcutaneous posterior tibial nerve stimulation provides significant short-term additive benefits in reflex volume and bladder capacity for incomplete spinal cord injury patients on antimuscarinics.

A study in Nucleic Acids Research reveals that a RARγ-SMARCA5 chromatin-remodeling axis maintains AR luminal identity and blocks lineage plasticity in enzalutamide-resistant prostate cancer, antagonizing ONECUT2 and presenting new therapeutic opportunities.

A reconstructed individual patient data analysis demonstrates that sequential intravesical gemcitabine and docetaxel matches or exceeds the oncologic efficacy of newly approved salvage agents for BCG-unresponsive NMIBC, reinforcing its role as an accessible, high-value standard of care.

A critical analysis of phytochemical nanoparticles in prostate cancer, evaluating whether enhanced drug delivery connects with measured epigenetic changes and clinical efficacy in oncology practice.